On the other hand, none of the 40 driver candidates were prognostic in esophageal carcinoma (ESCA) and cholangiocarcinoma (CHOL), which suggests the minimal contribution of JAK-STAT signaling in driving tumor progression in these cancer types (Fig. 2a). This evidence concerns the gene SOAT1 and carcinoma of esophagus.